Healthcare investment firm 1315 Capital LLC purchased Biocoat Inc. for an undisclosed amount.

The acquired company provides contract and original equipment manufacturers with hydrophilic biomaterial coatings for medical devices used in the neurovascular, cardiovascular, peripheral and ophthalmic markets. The acquisition is expected to help Biocoat further expand its research and development efforts and reach more customers.

Philadelphia-based 1315 Capital invests in commercial-stage healthcare services, medical technology and specialty pharmaceutical companies.